Skip to Main Content
An official website of the United States government

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Reset
Showing Most Recent
2501-2520 of 2638
Name Principal Investigator Institution Study Date Approved Project ID
Use of genetic ancestry versus self-reported race/ethnicity to predict lung-cancer risk in the PLCO Hormuzd Katki NCI PLCO Dec 8, 2021 PLCO-875
Use of GWAS data to address the association between Human Leukocyte Antigen (HLA) and cancer Zhiwei Liu National Cancer Institute PLCO Jun 22, 2018 PLCO-375
Use of head and neck cancer dataset Monika Khurana Independent PLCO Sep 20, 2017 PLCO-306
Use of Machine Learning and Decision Classifiers in the Analysis of PLCO Ovarian Data Katherine Andriole Brigham and Women's Hospital, Harvard Medical School PLCO Mar 29, 2016 PLCO-201
Use of neural networks in tissue abnormality detection Rafal Grzeszczuk AGH University of Science and Technology NLST Apr 11, 2017 NLST-299
Use of PLCO data to evaluate the performance of cancer risk models Thomas Ahearn Division of Cancer Genetics and Epidemiology, NCI PLCO Aug 22, 2022 PLCO-1025
Use of PLCO data to evaluate the performance of cancer risk models (extramural) Thomas Ahearn Division of Cancer Genetics and Epidemiology, NCI PLCO Jan 13, 2025 PLCO-1791
USE OF PLCO IMAGING DATASET FOR MACHINE LEARNING PROJECTS Mannudeep Kalra Massachusetts General Hospital PLCO May 29, 2018 PLCO-366
Use of prescriptive analytics in the desing of dynamic treatment regimes for breast cancer. Gustavo Mendoza Olguin Autonomous University of Puebla HIPB Jun 14, 2022 HIPB-9
Use of previous-day recalls of physical activity and sedentary behavior in epidemiologic studies: results from four instruments Charles Matthews NCI / DCEG / Metabolic Epidemiology Branch IDATA Aug 21, 2018 IDATA-25
Use of Radiomics and AI To Predict Malignancy in Indeterminate Lung Nodules Richard Lee The Royal Marsden Hospital NLST Nov 19, 2019 NLST-593
Use of Regression Discontinuity to Measure the Effect of PSA Screening Jonathan Shoag None PLCO May 28, 2014 PLCO-90
Use of the NLST CT and CXR Data to Better Understand Laten Tuberculosis and Risk of DIsease Progression William Stringer Harbor-UCLA Medical Center - LABIOMED NLST Feb 17, 2016 NLST-194
Use of Tobacco Biomarkers in Lung Cancer Risk Assessment Christine Lambert University of Minnesota PLCO Jan 30, 2020 PLCO-563
Using AI to predict cardiovascular disease yuankai wang University of Liverpool NLST Aug 8, 2023 NLST-1110
Using Artificial Intelligence for the automatic interpretation of chest CT images Hugo Aerts Dana-Farber Cancer Institute, Inc. NLST Nov 14, 2017 NLST-374
Using Big Data for Computer-Aided Diagnosis of Chest CTs Ronald Summers National Institutes of Health Clinical Center NLST Jun 30, 2017 NLST-319
Using Big Data for Computer-Aided Diagnosis of Chest X-Rays Ronald Summers National Institutes of Health Clinical Center PLCO Jun 9, 2017 PLCO-279
Using circulating metabolomes to understand pancreatic cancer genotype and phenotype and to explore their potential for risk assessment and early detection Herbert Yu University of Hawaii Cancer Center PLCO Jun 14, 2021 2021-0013
Using clinicopathological data to determine risk of metachronous advanced colorectal neoplasia among patients with adenomas Laura Hester Janssen Research and Development, LLC PLCO Nov 17, 2020 PLCO-688